The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
Open accessAbstract
Fungal biofilms produce a small number of persister cells which can tolerate high concentrations of fungicidal agents. Persisters form upon attachment to a surface, an important step in the pathogenesis of Candida strains. The periodic application of antimicrobial agents may select for strains with increased levels of persister cells. In order to test this possibility, 150 isolates of Candida albicans and C. glabrata were obtained from cancer patients who were at high risk for the development of oral candidiasis and who had been treated with topical chlorhexidine once a day. Persister levels were measured by exposing biofilms growing in the wells of microtiter plates to high concentrations of amphotericin B and plating for survivors. The persister levels of the isolates varied from 0.2 to 9%, and strains isolated from patients with long-term carriage had high levels of persisters. High-persister strains were isolated from every patient with Candida carriage of more than 8 consecutive weeks but from no patients with transient carriage. All of the high-persister isolates had an amphotericin B MIC that was the same as that for the wild type, indicating that these strains were drug-tolerant rather than drug-resistant mutants. Biofilms of the majority of high-persister strains also showed an increased tolerance to chlorhexidine and had the same MIC for this antimicrobial as the wild type. This study suggests that persister cells are clinically relevant, and antimicrobial therapy selects for high-persister strains in vivo. The drug tolerance of persisters may be a critical but overlooked component responsible for antimicrobial drug failure and relapsing infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LaFleur and colleagues reported that isolates from cancer patients with long-term C. albicans oral colonization displayed significantly higher levels of persistence compared to those from short-term carriers [13].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [13]
Citations
Cites
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Self-citationIsogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,695
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 907
Self-citationSpecialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A. L., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 848
Self-citationStandardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Moyed, H. S., & Bertrand, K. P. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.768-775.1983 · Cited by 641
Odds, F. C., & Bernaerts, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1923-1929.1994 · Cited by 631
Persisters: a distinct physiological state of E. coli
Khodursky, A. B., Zhang, Z., Devang, S., Kaldalu, N., Kurg, K., & Lewis, K. (2006) · Digital Repository Service (Northeastern University) · doi:10.1186/1471-2180-6-53 · Cited by 630
Self-citationPersister cells and the riddle of biofilm survival
Lewis, K. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0111-6 · Cited by 524
Self-citation
Research works printed but not linked: 1
- Ghannoum, M. A., and S. S. Radwan. 1990. The adherence process, p. 106-154. InCandida adherence to epithelial cells. CRC Press, Boca Raton, FL.
Cited by
Sorted by citations
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Self-citationPlatforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,527
Self-citationDefinitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313
Self-citationPersistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
Biofilm-specific antibiotic tolerance and resistance
Olsen, I. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2323-z · Cited by 742
Activated ClpP kills persisters and eradicates a chronic biofilm infection
Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., Leonard, S. N., Smith, R. D., Adkins, J., & Lewis, K. (2013) · Nature · doi:10.1038/nature12790 · Cited by 675
Self-citationPersister formation in Staphylococcus aureus is associated with ATP depletion
Conlon, B. P., Rowe, S. E., Gandt, A. B., Nuxoll, A. S., Donegan, N. P., Zalis, E. A., Clair, G., Adkins, J., Cheung, A. L., & Lewis, K. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.51 · Cited by 656
Self-citationMolecular Mechanisms Underlying Bacterial Persisters
Maisonneuve, E., & Gerdes, K. (2014) · Cell · doi:10.1016/j.cell.2014.02.050 · Cited by 668
Mulcahy, L. R., Burns, J. L., Lory, S. J., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 621
Self-citationGenetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 641
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
ATP-Dependent Persister Formation in Escherichia coli
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017) · mBio · doi:10.1128/mbio.02267-16 · Cited by 508
Self-citationEffect of tolerance on the evolution of antibiotic resistance under drug combinations
Liu, J., Gefen, O., Ronin, I., Bar‐Meir, M., & Balaban, N. Q. (2020) · Science · doi:10.1126/science.aay3041 · Cited by 489
Microbial Persistence and the Road to Drug Resistance
Cohen, N. R., Lobritz, M. A., & Collins, J. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.009 · Cited by 475
Maisonneuve, E., Castro-Camargo, M., & Gerdes, K. (2013) · Cell · doi:10.1016/j.cell.2013.07.048 · Cited by 439
RetractedFauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Formation, physiology, ecology, evolution and clinical importance of bacterial persisters
den Bergh, B. V., Fauvart, M., & Michiels, J. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux001 · Cited by 400
Windels, E. M., Michiels, J. E., Fauvart, M., Wenseleers, T., den Bergh, B. V., & Michiels, J. J. (2019) · The ISME Journal · doi:10.1038/s41396-019-0344-9 · Cited by 380
Resistance Toward Chlorhexidine in Oral Bacteria – Is There Cause for Concern?
Cieplik, F., Jakubovics, N. S., Buchalla, W., Maisch, T., Hellwig, E., & Al-Ahmad, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00587 · Cited by 424
Bridging the gap between viable but non-culturable and antibiotic persistent bacteria
Ayrapetyan, M., Williams, T. C., & Oliver, J. D. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.004 · Cited by 321
Concepts and Principles of Photodynamic Therapy as an Alternative Antifungal Discovery Platform
Dai, T., Fuchs, B. B., Coleman, J. J., Prates, R. A., Astrakas, C., Denis, T. G. S., Ribeiro, M. S., Mylonakis, E. E., Hamblin, M. R., & Tegos, G. P. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00120 · Cited by 304
Bacterial Persisters and Infection: Past, Present, and Progressing
Gollan, B., Grabe, G. J., Michaux, C., & Hélaine, S. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115650 · Cited by 287
Role of oxidative stress in persister tolerance
Wu, Y., Vulić, M., Keren, I., & Lewis, K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00921-12 · Cited by 276
Self-citationCandida albicans biofilms and polymicrobial interactions
Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843400 · Cited by 281
Candida glabrata: A review of its features and resistance
Rodrigues, C. F., Silva, S., & Henriques, M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2009-3 · Cited by 268
Antifungal drug-resistance mechanisms in Candida biofilms
Kaur, J., & Nobile, C. J. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102237 · Cited by 279
HipBA–promoter structures reveal the basis of heritable multidrug tolerance
Schumacher, M. A., Balani, P., Min, J., Chinnam, N. B., Hansen, S., Vulić, M., Lewis, K., & Brennan, R. G. (2015) · Nature · doi:10.1038/nature14662 · Cited by 243
Self-citationFighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222
Hicks, N. D., Yang, J., Zhang, X., Zhao, B. T., Grad, Y. H., Liu, L., Ou, X., Chang, Z., Xia, H., Zhou, Y., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0218-3 · Cited by 207
Persister Cells: Molecular Mechanisms Related to Antibiotic Tolerance
Lewis, K. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-28951-4_8 · Cited by 217
Self-citationImportance of Biofilms in Urinary Tract Infections: New Therapeutic Approaches
Soto, S. M. (2014) · Advances in Biology · doi:10.1155/2014/543974 · Cited by 219
Biofilm-Associated Infections: Antibiotic Resistance and Novel Therapeutic Strategies
Sun, F., Qu, F., Yan, L., Mao, P., Xia, P., Chen, H., & Zhou, D. (2013) · Future Microbiology · doi:10.2217/fmb.13.58 · Cited by 221
Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus
Johnson, P. J., & Levin, B. R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003123 · Cited by 187
Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases
Pacios, O., Blasco, L., Bleriot, I., Fernández-García, L., Bardanca, M. G., Ambroa, A., Bou, G., López, M. C., & Tomás, M. (2020) · Antibiotics · doi:10.3390/antibiotics9020065 · Cited by 189
Heterogeneous bacterial persisters and engineering approaches to eliminate them
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.09.002 · Cited by 185
General Mechanisms Leading to Persister Formation and Awakening
Wilmaerts, D., Windels, E. M., Verstraeten, N., & Michiels, J. J. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.03.007 · Cited by 186
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 205
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
Sharma, B., Brown, A. V., Matluck, N. E., Hu, L. T., & Lewis, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00864-15 · Cited by 175
Self-citationAnti-Candida albicans natural products, sources of new antifungal drugs: A review
Zida, A., Bamba, S., Yacouba, A., Ouedraogo-Traoré, R., & Guiguemdé, R. T. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.10.002 · Cited by 182
Persister Cells in Biofilm Associated Infections
Conlon, B. P., Rowe, S. E., & Lewis, K. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09782-4_1 · Cited by 175
Self-citationFresh Approaches to Anti-Infective Therapies
Nathan, C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003081 · Cited by 167
Drug resistance in eukaryotic microorganisms
Fairlamb, A. H., Gow, N. A. R., Matthews, K. R., & Waters, A. P. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.92 · Cited by 153
Song, F., & Ren, D. (2014) · Langmuir · doi:10.1021/la502029f · Cited by 150
Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics
Lechner, S., Lewis, K., & Bertram, R. (2012) · Microbial Physiology · doi:10.1159/000342449 · Cited by 155
Self-citationEfficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii
Defraine, V., Schuermans, J., Grymonprez, B., Govers, S. K., Aertsen, A., Fauvart, M., Michiels, J. J., Lavigne, R., & Briers, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00285-16 · Cited by 161
Developing a New Generation of Antimicrobial and Bioactive Dental Resins
Cheng, L., Zhang, K., Zhang, N., Melo, M. A. S., Weir, M. D., Zhou, X., Bai, Y., Reynolds, M. A., & Xu, H. H. K. (2017) · Journal of Dental Research · doi:10.1177/0022034517709739 · Cited by 156
New-found fundamentals of bacterial persistence
Kint, C. I., Verstraeten, N., Fauvart, M., & Michiels, J. J. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.08.009 · Cited by 154
Germain, E., Roghanian, M., Gerdes, K., & Maisonneuve, E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423536112 · Cited by 148
RetractedHigh Persister Mutants in Mycobacterium tuberculosis
Torrey, H. L., Keren, I., Via, L. E., Lee, J. S., & Lewis, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155127 · Cited by 147
Self-citationFungal persister cells: The basis for recalcitrant infections?
Wuyts, J., Van Dijck, P., & Holtappels, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007301 · Cited by 136
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Gold, B. S., & Nathan, C. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0031-2016 · Cited by 134
Dijck, P. V., Sjollema, J., Cammue, B. P. A., Lagrou, K., Berman, J. G., d’Enfert, C., Andes, D. R., Arendrup, M. C., Brakhage, A. A., Calderone, R., et al. (2018) · Microbial Cell · doi:10.15698/mic2018.07.638 · Cited by 136
Fasani, R. A., & Savageau, M. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301023110 · Cited by 119
New approaches to antimicrobial discovery
Lewis, K. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.002 · Cited by 126
Self-citationKaldalu, N., Hauryliuk, V., & Tenson, T. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7648-8 · Cited by 109
Regulation of the Escherichia coli HipBA Toxin-Antitoxin System by Proteolysis
Hansen, S., Vulić, M., Min, J., Yen, T.-J., Schumacher, M. A., Brennan, R. G., & Lewis, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039185 · Cited by 101
Self-citationMichiels, J. E., den Bergh, B. V., Verstraeten, N., Fauvart, M., & Michiels, J. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00757-16 · Cited by 97
Li, P., Seneviratne, C. J., Alpi, E., Vizcaino, J. A., & Jin, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-15 · Cited by 95
Aspergillus Biofilm In Vitro and In Vivo
Beauvais, A., & Latgé, J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0017-2015 · Cited by 102
Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment
Bartell, J. A., Cameron, D. R., Mojsoska, B., Haagensen, J. A. J., Pressler, T., Sommer, L. M., Lewis, K., Molin, S., & Johansen, H. K. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009112 · Cited by 90
Self-citationA Quorum Sensing Small Volatile Molecule Promotes Antibiotic Tolerance in Bacteria
Que, Y., Hazan, R., Strobel, B., Maura, D., He, J., Kesarwani, M., Panopoulos, P., Tsurumi, A., Giddey, M., Wilhelmy, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080140 · Cited by 86
Bacterial persistence: Fundamentals and clinical importance
Jung, S., Ryu, C., & Kim, J. (2019) · The Journal of Microbiology · doi:10.1007/s12275-019-9218-0 · Cited by 79
Antibiotic persistence and tolerance: not just one and the same
Ronneau, S., Hill, P. W. S., & Hélaine, S. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.09.017 · Cited by 83
The vulnerable versatility of Salmonella antibiotic persisters during infection
Hill, P. W. S., Moldoveanu, A. L., Sargen, M. R., Ronneau, S., Glegola-Madejska, I., Beetham, C. M., Fisher, R. A., & Hélaine, S. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.10.002 · Cited by 84
Pan, J., Bahar, A. A., Syed, H., & Ren, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045778 · Cited by 78
Kim, W., Conery, A. L., Rajamuthiah, R., Fuchs, B. B., Ausubel, F. M., & Mylonakis, E. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127640 · Cited by 75
Wu, X., Zhang, S., Li, H., Shen, L., Dong, C., Sun, Y., Chen, H., Xu, B., Zhuang, W., Deighton, M. A., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01117 · Cited by 80
Survival of Bactericidal Antibiotic Treatment by a Persister Subpopulation of Listeria monocytogenes
Knudsen, G. M., Ng, Y., & Gram, L. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02184-13 · Cited by 69
Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence
Alanio, A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136223 · Cited by 62
Persistence and resistance as complementary bacterial adaptations to antibiotics
Vogwill, T., Comfort, A. C., Furió, V., & MacLean, R. C. (2016) · Journal of Evolutionary Biology · doi:10.1111/jeb.12864 · Cited by 67
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 69
Fungal biofilm inhibitors from a human oral microbiome-derived bacterium
Wang, X., Du, L., You, J., King, J. B., & Cichewicz, R. H. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06856g · Cited by 67
Wang, X., You, J., King, J. B., Powell, D. R., & Cichewicz, R. H. (2012) · Journal of Natural Products · doi:10.1021/np2009994 · Cited by 66
Smith, A., Kaczmar, A., Bamford, R. A., Smith, C., Frustaci, S., Kovacs-Simon, A., O’Neill, P., Moore, K., Paszkiewicz, K. H., Titball, R. W., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01739 · Cited by 67
LaFleur, M. D., Lucumi, E., Napper, A. D., Diamond, S. L., & Lewis, K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq530 · Cited by 59
Self-citationThe arsenal of pathogens and antivirulence therapeutic strategies for disarming them
Hadjifrangiskou, M., & Brannon, J. R. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s98939 · Cited by 58
Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa
Narayanaswamy, V. P., Keagy, L. L., Duris, K., Wiesmann, W. P., Loughran, A. J., Townsend, S. M., & Baker, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01724 · Cited by 60
You, J., Du, L., King, J. B., Hall, B. E., & Cichewicz, R. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400009f · Cited by 60
Decline in nitrosative stress drives antibiotic persister regrowth during infection
Ronneau, S., Michaux, C., & Hélaine, S. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.05.002 · Cited by 58
The toxin-antitoxin systemtisB-istR1
Wagner, E. G. H., & Unoson, C. (2012) · RNA Biology · doi:10.4161/rna.22578 · Cited by 56
The Role of Proteomics in Bacterial Response to Antibiotics
Tsakou, F., Jersie-Christensen, R., Jenssen, H., & Mojsoska, B. (2020) · Pharmaceuticals · doi:10.3390/ph13090214 · Cited by 60
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 58
The within-host evolution of antimicrobial resistance in Mycobacterium tuberculosis
Castro, R. A. D., Borrell, S., & Gagneux, S. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa071 · Cited by 56
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 61
Active efflux in dormant bacterial cells – New insights into antibiotic persistence
Pu, Y., Ke, Y., & Bai, F. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.11.002 · Cited by 52
Nh125 Kills Methicillin-Resistant Staphylococcus Aureus Persisters by Lipid Bilayer Disruption
Kim, W., Fricke, N., Conery, A. L., Fuchs, B. B., Rajamuthiah, R., Jayamani, E., Vlahovska, P. M., Ausubel, F. M., & Mylonakis, E. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.189 · Cited by 47
Aspergillus Biofilm In Vitro and In Vivo
Beauvais, A., & Latgé, J. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch8 · Cited by 47
Rodrigues, C. F., & Henriques, M. (2017) · Pathogens · doi:10.3390/pathogens6040062 · Cited by 48
Stepanyan, K., Wenseleers, T., Duéñez‐Guzmán, E. A., Muratori, F. B., den Bergh, B. V., Verstraeten, N., Meester, L. D., Verstrepen, K. J., Fauvart, M., & Michiels, J. J. (2015) · Molecular Ecology · doi:10.1111/mec.13127 · Cited by 44
Ankomah, P., Johnson, P. J., & Levin, B. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003300 · Cited by 45
Putrinš, M., Kogermann, K., Lukk, E., Lippus, M., Varik, V., & Tenson, T. (2015) · Infection and Immunity · doi:10.1128/iai.02725-14 · Cited by 45
Extreme Antibiotic Persistence via Heterogeneity-Generating Mutations Targeting Translation
Khare, A., & Tavazoie, S. (2020) · mSystems · doi:10.1128/msystems.00847-19 · Cited by 46
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge
Roudbary, M., Vahedi‐Shahandashti, R., dos Santos, A. L. S., Mohammadi, S. R., Aslani, P., Lass‐Flörl, C., & Rodrigues, C. F. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1950121 · Cited by 46
Bojsen, R., Regenberg, B., Gresham, D., & Folkesson, A. (2016) · Scientific Reports · doi:10.1038/srep21874 · Cited by 42
Ramage, G., Zalewska, A., Cameron, D. A., Sherry, L., Murray, C. A., Finnegan, M. B., Loewy, Z. G., & Jagger, D. C. (2012) · Journal of Prosthodontics · doi:10.1111/j.1532-849x.2012.00865.x · Cited by 40
Lagree, K., & Mitchell, A. P. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0024-2016 · Cited by 41
Antibiotic tolerance and persistence have distinct fitness trade-offs
Michaux, C., Ronneau, S., Giorgio, R. T., & Hélaine, S. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010963 · Cited by 42
Araujo, H. C., da Silva, A. C. G., Paião, L. I., Magario, M. K. W., Frasnelli, S. C. T., Oliveira, S. H. P., Pessan, J. P., & Monteiro, D. R. (2020) · Journal of Dentistry · doi:10.1016/j.jdent.2020.103453 · Cited by 39
Metadata
- Authors
- LaFleur, M. D., Qi, Q., & Lewis, K.
- Affiliations
- Northeastern University (US)
- Antimicrobial Discovery Center and Department of Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115
- Corresponding author
- Lewis, Kim
- ORCID
- Lewis, Kim
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 54
- Issue
- 1
- Pages
- 39-44
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2798516
- OpenAlex
- W2115712103
- Cited by
- 237
- References
- 32
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 14 · 2023: 9 · 2022: 16 · 2021: 21 · 2020: 18 · 2019: 16 · 2018: 9 · 2017: 15 · 2016: 21 · 2015: 24 · 2014: 12 · 2013: 24 · 2012: 17
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30400498)
- National Institute of General Medical Sciences (R01GM061162)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, Candida glabrata, persister cells, fungal biofilms, oral candidiasis, drug tolerance, antimicrobial selection, cancer patients, infection relapse
- MeSH terms
- Adult, Aged, Candida albicans, Candidiasis, Carrier State, Chlorhexidine, Dose-Response Relationship, Drug, Female, Genes, Fungal, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Mouth, Mouthwashes, Mutation, Neoplasms, Biofilms, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review